Susquehanna International Group, LLP Horizon Therapeutics Public LTD CO Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $1.18 Million - $1.39 Million	11,972 Added 3.56%	347,967 $40.3 Million
Q2 2023 Aug 11, 2023	SELL	$96.34 - $112.38 $1.79 Million - $2.09 Million	-18,559 Reduced 5.23%	335,995 $34.6 Million
Q1 2023 May 16, 2023	SELL	$107.32 - $113.5 $37.2 Million - $39.4 Million	-346,811 Reduced 49.45%	354,554 $38.7 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $16.4 Million - $30 Million	263,486 Added 60.17%	701,365 $79.8 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $506,240 - $727,484	-8,592 Reduced 1.92%	437,879 $27.1 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $21.8 Million - $32 Million	275,097 Added 160.52%	446,471 $35.6 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $1.53 Million - $1.94 Million	-17,693 Reduced 9.36%	171,374 $18 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $489,744 - $595,832	-4,969 Reduced 2.56%	189,067 $20.4 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $7.21 Million - $8.66 Million	78,431 Added 67.84%	194,036 $21.3 Million
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $25.7 Million - $28.6 Million	-297,796 Reduced 72.04%	115,605 $10.8 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $3.72 Million - $4.95 Million	51,845 Added 14.34%	413,401 $38 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $18.2 Million - $22.9 Million	271,811 Added 302.87%	361,556 $26.4 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $4.15 Million - $6.01 Million	75,218 Added 517.78%	89,745 $6.97 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $554,955 - $1.05 Million	-18,376 Reduced 55.85%	14,527 $807,000
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $316,122 - $490,136	12,711 Added 62.95%	32,903 $975,000
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $99,049 - $142,829	-3,895 Reduced 16.17%	20,192 $731,000
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $3.02 Million - $3.68 Million	-131,417 Reduced 84.51%	24,087 $656,000
Q2 2019 Nov 14, 2019	BUY	$22.81 - $28.48 $3.55 Million - $4.43 Million	155,504 New	155,504 $3.74 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account